Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracaine vs Phenol for Local Anesthesia During Intratympanic Steroid Injection
NCT04794842Phase 1Unknown
- Sponsor
- Our Lady of the Lake Regional Medical Center
- Start
- Aug 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of tetracaine in idiopathic sudden sensorineural hearing loss (ISSNHL) and Ménière's disease (2 arms), sponsored by Our Lady of the Lake Regional Medical Center. Primary endpoint: Difference in Pain Score at 6 months. Status: unknown.
02
Drugs
tetracaine
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)Ménière's disease
Beyond the preview
Go deeper on NCT04794842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04794842.